Bank of America’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.95K Sell
803
-11,772
-94% -$87.2K ﹤0.01% 6241
2025
Q1
$108K Sell
12,575
-25,583
-67% -$220K ﹤0.01% 5470
2024
Q4
$1.36M Sell
38,158
-1,443
-4% -$51.6K ﹤0.01% 4023
2024
Q3
$1.87M Buy
39,601
+33,210
+520% +$1.57M ﹤0.01% 3894
2024
Q2
$321K Sell
6,391
-1,992
-24% -$100K ﹤0.01% 4829
2024
Q1
$939K Buy
8,383
+1,900
+29% +$213K ﹤0.01% 4196
2023
Q4
$376K Buy
6,483
+1,788
+38% +$104K ﹤0.01% 4818
2023
Q3
$149K Sell
4,695
-7,365
-61% -$234K ﹤0.01% 5198
2023
Q2
$992K Sell
12,060
-28,575
-70% -$2.35M ﹤0.01% 4029
2023
Q1
$4.18M Buy
40,635
+10,206
+34% +$1.05M ﹤0.01% 3143
2022
Q4
$4.46M Buy
30,429
+14,523
+91% +$2.13M ﹤0.01% 2986
2022
Q3
$2.69M Buy
15,906
+13,635
+600% +$2.3M ﹤0.01% 3418
2022
Q2
$262K Buy
2,271
+891
+65% +$103K ﹤0.01% 5163
2022
Q1
$138K Sell
1,380
-334
-19% -$33.4K ﹤0.01% 5919
2021
Q4
$266K Sell
1,714
-1,381
-45% -$214K ﹤0.01% 5526
2021
Q3
$730K Buy
3,095
+886
+40% +$209K ﹤0.01% 4581
2021
Q2
$750K Buy
2,209
+873
+65% +$296K ﹤0.01% 4441
2021
Q1
$540K Sell
1,336
-13,755
-91% -$5.56M ﹤0.01% 4685
2020
Q4
$10M Sell
15,091
-8,845
-37% -$5.88M ﹤0.01% 2155
2020
Q3
$11.1M Buy
23,936
+6,094
+34% +$2.84M ﹤0.01% 1957
2020
Q2
$10.4M Buy
17,842
+5,772
+48% +$3.38M ﹤0.01% 1948
2020
Q1
$1.76M Buy
12,070
+10,487
+662% +$1.53M ﹤0.01% 3173
2019
Q4
$227K Sell
1,583
-42
-3% -$6.02K ﹤0.01% 4786
2019
Q3
$64K Sell
1,625
-242
-13% -$9.53K ﹤0.01% 5400
2019
Q2
$189K Buy
1,867
+478
+34% +$48.4K ﹤0.01% 4925
2019
Q1
$183K Buy
1,389
+117
+9% +$15.4K ﹤0.01% 4844
2018
Q4
$129K Buy
1,272
+1,188
+1,414% +$120K ﹤0.01% 5047
2018
Q3
$21K Buy
84
+7
+9% +$1.75K ﹤0.01% 5749
2018
Q2
$34K Sell
77
-104
-57% -$45.9K ﹤0.01% 5586
2018
Q1
$72K Sell
181
-183
-50% -$72.8K ﹤0.01% 5166
2017
Q4
$150K Buy
364
+154
+73% +$63.5K ﹤0.01% 4776
2017
Q3
$91K Buy
+210
New +$91K ﹤0.01% 4926